The results indicated that high expression levels of eIF4E and p-4EBP1 had the potential to become predictive biomarkers for patients with HNSCC who receive adjuvant radiotherapy (Fig 3). The gene discussed is EIF4EBP1; the disease is head and neck squamous cell carcinoma.